Literature DB >> 20358244

Successful treatment of three children with post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis.

H Ozdemir, A Tapisiz, E Ciftçi, E Ince, H Mokhtari, H Güriz, A D Aysev, U Doğru.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20358244     DOI： 10.1007/s15010-010-0018-z

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  13 in total

1.  Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis.

Authors:  M E Jiménez-Mejías; C Pichardo-Guerrero; F J Márquez-Rivas; D Martín-Lozano; T Prados; J Pachón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-03-19       Impact factor: 3.267

2.  Successful treatment of Acinetobacter meningitis with intrathecal polymyxin E.

Authors:  Mony Benifla; Gideon Zucker; Avi Cohen; Michael Alkan
Journal:  J Antimicrob Chemother       Date:  2004-06-09       Impact factor: 5.790

3.  Acinetobacter baumanii meningitis: a rare complication of incidental durotomy.

Authors:  Dorian Joseph deFreitas; John P McCabe
Journal:  J Spinal Disord Tech       Date:  2004-04

Review 4.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

5.  Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections.

Authors:  Mireia Saballs; Miquel Pujol; Fe Tubau; Carmen Peña; Abelardo Montero; M Angeles Domínguez; Francesc Gudiol; Javier Ariza
Journal:  J Antimicrob Chemother       Date:  2006-09       Impact factor: 5.790

6.  Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review.

Authors:  John Ng; Iain B Gosbell; John A Kelly; Michael J Boyle; John K Ferguson
Journal:  J Antimicrob Chemother       Date:  2006-08-17       Impact factor: 5.790

7.  Treatment of multidrug-resistant Acinetobacter baumannii meningitis with ampicillin/sulbactam.

Authors:  M E Jiménez-Mejías; J Pachón; B Becerril; J Palomino-Nicás; A Rodríguez-Cobacho; M Revuelta
Journal:  Clin Infect Dis       Date:  1997-05       Impact factor: 9.079

8.  Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments.

Authors:  A Rodríguez Guardado; A Blanco; V Asensi; F Pérez; J C Rial; V Pintado; E Bustillo; M Lantero; E Tenza; M Alvarez; J A Maradona; J A Cartón
Journal:  J Antimicrob Chemother       Date:  2008-02-15       Impact factor: 5.790

Review 9.  Nosocomial acinetobacter meningitis secondary to invasive procedures: report of 25 cases and review.

Authors:  Y Siegman-Igra; S Bar-Yosef; A Gorea; J Avram
Journal:  Clin Infect Dis       Date:  1993-11       Impact factor: 9.079

10.  Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam.

Authors:  Anna S Levin; Carlos E Levy; A Edison I Manrique; Eduardo A S Medeiros; Silvia F Costa
Journal:  Int J Antimicrob Agents       Date:  2003-01       Impact factor: 5.283
View more
  9 in total

Review 1.  Intrathecal/intraventricular colistin in external ventricular device-related infections by multi-drug resistant Gram negative bacteria: case reports and review.

Authors:  O Bargiacchi; A Rossati; P Car; D Brustia; R Brondolo; F Rosa; P L Garavelli; F G De Rosa
Journal:  Infection       Date:  2014-04-12       Impact factor: 3.553

2.  Molecular epidemiology and the clinical significance of Acinetobacter baumannii complex isolated from cerebrospinal fluid in neurosurgical intensive care unit patients.

Authors:  G Bayramoglu; S Kaya; Y Besli; E Cakır; G Can; O Akıneden; F Aydin; I Koksal
Journal:  Infection       Date:  2011-10-29       Impact factor: 3.553

3.  Multidrug-resistant Acinetobacter baumannii infection in children.

Authors:  Maia De Luca; Giulia Angelino; Francesca Ippolita Calò Carducci; Alessandra Martino; Stefania Bernardi; Paola Bernaschi; Michaela Carletti; Patrizia D'Argenio; Paolo Palma
Journal:  BMJ Case Rep       Date:  2011-08-11

Review 4.  Acinetobacter baumannii meningitis in children: a case series and literature review.

Authors:  Jiying Xiao; Chenmei Zhang; Sheng Ye
Journal:  Infection       Date:  2018-10-16       Impact factor: 3.553

Review 5.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

6.  Significance of nucleic acid testing in diagnosis and treatment of post-neurosurgical meningitis caused by multidrug-resistant Acinetobacter baumannii: a case report.

Authors:  Ngo Tat Trung; Trinh Van Son; Dao Thanh Quyen; Dang Thi Viet Anh; Vu Viet Sang; Nguyen Xuan Lam; Nguyen Dang Manh; Vuong Phuc Duong; Bui Tri Cuong; Quyen Dang Tuyen; Nguyen Xuan Chinh; Phan Quoc Hoan; Hoang Van Tong; Christian G Meyer; Le Huu Song
Journal:  J Med Case Rep       Date:  2016-11-03

7.  Postoperative multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intravenous doxycycline and intraventricular gentamicin: A case report.

Authors:  Xia Wu; Lu Wang; Ying-Zi Ye; Hui Yu
Journal:  World J Clin Cases       Date:  2019-12-26       Impact factor: 1.337

Review 8.  Convergence of Biofilm Formation and Antibiotic Resistance in Acinetobacter baumannii Infection.

Authors:  Subhasree Roy; Goutam Chowdhury; Asish K Mukhopadhyay; Shanta Dutta; Sulagna Basu
Journal:  Front Med (Lausanne)       Date:  2022-03-24

Review 9.  Intrathecal/Intraventricular Colistin for Antibiotic-Resistant Bacterial CNS Infections in Pediatric Population: A Systematic Review.

Authors:  Ibrahim Alnaami; Zubaidah Alahmari
Journal:  Trop Med Infect Dis       Date:  2022-03-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.